Literature DB >> 24051177

Elevated homocysteine level in siblings of patients with schizophrenia.

Vadim Geller1, Michael Friger, Ben-Ami Sela, Joseph Levine.   

Abstract

Increased homocysteine plasma levels were reported in patients with schizophrenia and Levine et al. (2002) suggested that such increase characterizes mainly males. In the following study we examined whether such increased levels also characterize male siblings of schizophrenia patients. Forty-four pairs of schizophrenia patients and their corresponding healthy male siblings were recruited and sampled for homocysteine. We also had age-matched controls for each of the sibling. The median homocysteine plasma level for patients was 13.0 µMol/L and 11.7 µMol/L for their male siblings compared with a median of 10.9 µMol/L for the siblings' controls. There was no significant difference between homocysteine plasma level in patients and their siblings. Significant difference was found for homocysteine plasma level between the siblings' group and their matched controls. A partial correlation of Ln plasma homocysteine level between patients and their siblings was found to be close to a zero correlation of -0.089, p=0.57 for the whole study group and -0.15, p=0.38 in the male-male patient-sibling pairs. Our results show that elevated homocysteine plasma level may characterize schizophrenia patients' male siblings, a finding that seems to agree with previous studies suggesting elevated homocysteine level as a risk factor for developing schizophrenia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Homocysteine; Schizophrenia; Siblings

Mesh:

Substances:

Year:  2013        PMID: 24051177     DOI: 10.1016/j.psychres.2013.08.016

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  8 in total

1.  Retinal Ganglion Cell Loss and Mild Vasculopathy in Methylene Tetrahydrofolate Reductase (Mthfr)-Deficient Mice: A Model of Mild Hyperhomocysteinemia.

Authors:  Shanu Markand; Alan Saul; Penny Roon; Puttur Prasad; Pamela Martin; Rima Rozen; Vadivel Ganapathy; Sylvia B Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

2.  Elevated homocysteine level in first-episode schizophrenia patients--the relevance of family history of schizophrenia and lifetime diagnosis of cannabis abuse.

Authors:  Blazej Misiak; Dorota Frydecka; Ryszard Slezak; Patryk Piotrowski; Andrzej Kiejna
Journal:  Metab Brain Dis       Date:  2014-03-30       Impact factor: 3.584

3.  Microstructural white matter tissue characteristics are modulated by homocysteine: a diffusion tensor imaging study.

Authors:  Jung-Lung Hsu; Wei-Hung Chen; Chyi-Huey Bai; Jyu-Gang Leu; Chien-Yeh Hsu; Max A Viergever; Alexander Leemans
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

4.  Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients.

Authors:  Błażej Misiak; Dorota Frydecka; Łukasz Łaczmański; Ryszard Ślęzak; Andrzej Kiejna
Journal:  Eur J Clin Pharmacol       Date:  2014-10-08       Impact factor: 2.953

Review 5.  Homocysteine levels in schizophrenia and affective disorders-focus on cognition.

Authors:  Ahmed A Moustafa; Doaa H Hewedi; Abeer M Eissa; Dorota Frydecka; Błażej Misiak
Journal:  Front Behav Neurosci       Date:  2014-10-06       Impact factor: 3.558

6.  Early-Onset Schizophrenia: A Special Phenotype of the Disease Characterized by Increased MTHFR Polymorphisms and Aggravating Symptoms.

Authors:  Lin Wan; Jing Wei
Journal:  Neuropsychiatr Dis Treat       Date:  2021-08-03       Impact factor: 2.570

7.  The Effects of Plasma Homocysteine Level on the Risk of Three Major Psychiatric Disorders: A Mendelian Randomization Study.

Authors:  Jing Yu; Ranran Xue; Qiuling Wang; Hao Yu; Xia Liu
Journal:  Front Psychiatry       Date:  2022-03-21       Impact factor: 4.157

8.  Prevalence and clinical demography of hyperhomocysteinemia in Han Chinese patients with schizophrenia.

Authors:  Yating Yang; Juan Wang; Zulun Xiong; Xianhu Yao; Yulong Zhang; Xiaoshuai Ning; Yi Zhong; Zhiwei Liu; Yelei Zhang; Tongtong Zhao; Lei Xia; Kai Zhang; Huanzhong Liu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-06-08       Impact factor: 5.270

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.